TREM2 and Alzheimer disease: Besides previously reported beneficial effects of a TREM2‐related microglial response in advanced AD, we show that in patients with earliest Aβ abnormalities, microglial activation is associated with increases in p‐tau181 and neuroinflammation which is reflected in glucose hypermetabolism.